Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

This provides full disease control: intravenous SPEVIGO treats GPP flares, while subcutaneous SPEVIGO prevents them. 5 ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...

AnaptysBio (NASDAQ:ANAB) stock maintained its Neutral rating and $19.00 price target from H.C. Wainwright. Currently trading ...

Chronic stress is linked to a weakened immune system and increased cancer diagnosis risk, though psychological factors alone ...

Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A novel study showed that spontaneous neural activity and functional connectivity in certain brain regions correlated with ...

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

Serum soluble interleukin-2 receptor (sIL-2R) levels have been a great diagnostic tool for non-Hodgkin lymphoma (NHL) and ...

Recent developments in the field include an evolving treatment landscape and the development of evidence-based guidelines.